Involvement of cytokines in eating disorders: a critical review of the human literature

被引:60
作者
Corcos, M
Guilbaud, O
Paterniti, S
Moussa, M
Chambry, J
Chaouat, G
Consoli, SM
Jeammet, P
机构
[1] Dept Psychiat Adolescent & Young Adult Psychiat, F-75014 Paris, France
[2] Hop Europeen Georges Pompidou, Dept Psychol & Psychiat, F-75015 Paris, France
[3] Hop Antoine Beclere, INSERM, U131, F-92140 Clamart, France
关键词
cytokines; anorexia nervosa; bulimia nervosa; malnutrition;
D O I
10.1016/S0306-4530(02)00021-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A number of findings from clinical and animal studies indicate that pro-inflammatory cytokines may play roles in eating disorders. The measurement of pro-inflammatory cytokines (IL-l, IL-6, TNFalpha), which are known to decrease food intake, provides highly variable data from which firm conclusions cannot be drawn. In most of the longitudinal studies where pro-inflammatory cytokines have been shown to be impaired in anorexia or bulimia nervosa, a return to normal values was observed after renutrition. However these findings do not exclude the possibility that pro-inflammatory cytokines might be overproduced in specific brain areas and act locally without concomitantly increased serum or immune production. It was also pointed out that the production of the major type-1 cytokines (especially IL-2) was depressed in anorexia nervosa. It remains unclear whether this is due to undernutrition or to a specific underlying cause common to eating disorders. The impaired cytokine profile observed in eating disorders could be related to several factors including impaired nutrition, psychopathological and neuroendocrine factors. More particular attention should be devoted to the deregulation of the anti/pro-inflammatory balance: Deregulation of the cytokine network may be responsible for medical complications in eating disorder patients who are afflicted with chronic underweight. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:229 / 249
页数:21
相关论文
共 95 条
[1]  
Allende LM, 1998, IMMUNOLOGY, V94, P543, DOI 10.1046/j.1365-2567.1998.00548.x
[2]  
BAMBILLA F, 1996, PSYCHIAT RES, V62, P97
[3]  
BAMBILLA F, 2001, PSYCHONEUROENDOCRINO, V26, P393
[4]   Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity [J].
Baranowska, B ;
Radzikowska, M ;
Wasilewska-Dziubinska, E ;
Roguski, K ;
Borowiec, M .
DIABETES OBESITY & METABOLISM, 2000, 2 (02) :99-103
[5]   CYTOKINE PRODUCTION IN ANOREXIA-NERVOSA [J].
BESSLER, H ;
KARP, L ;
NOTTI, I ;
APTER, A ;
TYANO, S ;
DJALDETTI, M ;
WEIZMAN, R .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (03) :237-243
[6]   INTERLEUKIN-1 IN MALNUTRITION [J].
BHASKARAM, P ;
SIVAKUMAR, B .
ARCHIVES OF DISEASE IN CHILDHOOD, 1986, 61 (02) :182-185
[7]   Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes [J].
Bluthe, RM ;
Michaud, B ;
Kelley, KW ;
Dantzer, R .
NEUROREPORT, 1996, 7 (15-17) :2823-2827
[8]   LEUKOPENIA IN ANOREXIA-NERVOSA - LACK OF INCREASED RISK OF INFECTION [J].
BOWERS, TK ;
ECKERT, E .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (10) :1520-1523
[9]   T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders .2. Bulimia nervosa [J].
Brambilla, F ;
Brunetta, M ;
Draisci, A ;
Peirone, A ;
Perna, G ;
Sacerdote, P ;
Manfredi, B ;
Panerai, AE .
PSYCHIATRY RESEARCH, 1995, 59 (1-2) :51-56
[10]   Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa [J].
Brambilla, F ;
Monti, D ;
Franceschi, C .
PSYCHIATRY RESEARCH, 2001, 103 (2-3) :107-114